News
The FDA is allowing Sarepta to resume shipments of Elevidys (delandistrogene moxeparvovec) to ambulatory patients with Duchenne muscular dystrophy.
1d
GlobalData on MSNHansa’s Idefirix shows potential as pre-treatment to ElevidysHansa Biosciences’ Idefirix (imlifidase) has reduced patients’ antibodies to a level that allows dosing in patients with ...
As Laura Loomer wields a terrifying amount of power, other far-right influencers are accusing her of being a “plant.” ...
3hOpinion
The New Republic on MSNTrump’s DOJ Reveals It Has Recording of Ghislaine MaxwellIn his first town hall since voting in favor of Donald Trump’s “big, beautiful bill,” Nebraska Representative Mike Flood had ...
Detailed price information for Sarepta Therapeutics (SRPT-Q) from The Globe and Mail including charting and trades.
I do not work for Big Pharma. I work in support of President Trump on the outside of the administration,’ Loomer tells The ...
6hOpinion
The New Republic on MSNElon Musk’s Worst Nightmare About DOGE Is Starting to Come TrueThat includes 450 meteorologists, hydrologists, and radar technicians to replace the ones that were let go from the agency at ...
Sarepta and Capricor learned of key regulatory decisions from the media and investors, and Duchenne muscular dystrophy ...
Parents of boys with Duchenne muscular dystrophy weigh in on drug innovation and medical regulation.
I understand the heartbreak of watching someone you love spiral. But compassion cannot mean locking people up,” writes a STAT ...
In the latest episode of STATus Report, Alex Hogan breaks down the confusing, heartbreaking saga of Sarepta and its gene ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results